These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33435572)

  • 1. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma.
    Woo HY; Yoo SY; Heo J
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peretinoin as an adjuvant therapy for hepatocellular carcinoma.
    Tan CK
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1201-1210. PubMed ID: 27649418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.
    Honda M; Yamashita T; Yamashita T; Arai K; Sakai Y; Sakai A; Nakamura M; Mizukoshi E; Kaneko S
    BMC Cancer; 2013 Apr; 13():191. PubMed ID: 23587162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review).
    Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H
    Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peretinoin, an acyclic retinoid, suppresses steatohepatitis and tumorigenesis by activating autophagy in mice fed an atherogenic high-fat diet.
    Okada H; Takabatake R; Honda M; Takegoshi K; Yamashita T; Nakamura M; Shirasaki T; Sakai Y; Shimakami T; Nagata N; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Jun; 8(25):39978-39993. PubMed ID: 28591717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of recurrent hepatocellular carcinoma with retinoid].
    Moriwaki H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1980-4. PubMed ID: 11791378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
    Shimizu M; Takai K; Moriwaki H
    Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro.
    Shimakami T; Honda M; Shirasaki T; Takabatake R; Liu F; Murai K; Shiomoto T; Funaki M; Yamane D; Murakami S; Lemon SM; Kaneko S
    Sci Rep; 2014 Apr; 4():4688. PubMed ID: 24732793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.
    Okita K; Izumi N; Ikeda K; Osaki Y; Numata K; Ikeda M; Kokudo N; Imanaka K; Nishiguchi S; Kondo S; Nishigaki Y; Shiomi S; Ueshima K; Isoda N; Karino Y; Kudo M; Tanaka K; Kaneko S; Moriwaki H; Makuuchi M; Okusaka T; Hayashi N; Ohashi Y; Kumada H;
    J Gastroenterol; 2015 Jun; 50(6):667-74. PubMed ID: 25209978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids in liver fibrosis and cancer.
    Okuno M; Kojima S; Akita K; Matsushima-Nishiwaki R; Adachi S; Sano T; Takano Y; Takai K; Obora A; Yasuda I; Shiratori Y; Okano Y; Shimada J; Suzuki Y; Muto Y; Moriwaki Y
    Front Biosci; 2002 Jan; 7():d204-18. PubMed ID: 11779708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study.
    Okita K; Izumi N; Matsui O; Tanaka K; Kaneko S; Moriwaki H; Ikeda K; Osaki Y; Numata K; Nakachi K; Kokudo N; Imanaka K; Nishiguchi S; Okusaka T; Nishigaki Y; Shiomi S; Kudo M; Ido K; Karino Y; Hayashi N; Ohashi Y; Makuuchi M; Kumada H;
    J Gastroenterol; 2015 Feb; 50(2):191-202. PubMed ID: 24728665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.
    Takai K; Okuno M; Yasuda I; Matsushima-Nishiwaki R; Uematsu T; Tsurumi H; Shiratori Y; Muto Y; Moriwaki H
    Intervirology; 2005; 48(1):39-45. PubMed ID: 15785088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.
    Funaki M; Kitabayashi J; Shimakami T; Nagata N; Sakai Y; Takegoshi K; Okada H; Murai K; Shirasaki T; Oyama T; Yamashita T; Ota T; Takuwa Y; Honda M; Kaneko S
    Sci Rep; 2017 Dec; 7(1):16978. PubMed ID: 29208982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids in cancer chemoprevention.
    Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H
    Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro.
    Murai K; Shirasaki T; Honda M; Shimizu R; Shimakami T; Nakasho S; Shirasaki N; Okada H; Sakai Y; Yamashita T; Kaneko S
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
    Nagaki M; Shimizu M; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.
    Okuno M; Kojima S; Moriwaki H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1329-35. PubMed ID: 11851828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.